Skip to content

Integrated Maternal Psychosocial Assessment to Care Trial (IMPACT) Full Trial

Integrated Maternal Psychosocial Assessment to Care Trial (IMPACT): Intervening Early to Improve Maternal and Family Well-being.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01901796
Enrollment
5000
Registered
2013-07-17
Start date
2014-01-31
Completion date
2020-12-31
Last updated
2019-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

Anxiety, Depression, CBT

Brief summary

We hypothesize that the intervention will: (1) offer a feasible approach for providing mental healthcare to pregnant women and have a high level of acceptability by pregnant women and healthcare providers; (2) reduce symptoms of depression, stress, anxiety, and parenting stress; improve parenting competence, coping, and relationship adjustment compared to usual care; and (3) reduce the risk of poor maternal-infant attachment. As such, this early intervention holds promise for reducing maternal mental health morbidity and its negative influences on infants, children, and families.

Detailed description

One of the main reasons that women do not receive treatment is that their mood and anxiety problems are not detected. Despite recommendations and high rates of acceptance by providers and women, only a minority of providers conduct psychosocial assessments as part of routine prenatal care. Computer-based 'screening' is an acceptable and feasible approach to assessment of sensitive issues including prenatal and postnatal intimate partner violence, mental health problems, and postpartum depression by patients and providers. It is well-suited for busy clinical settings and is advantageous in that it offers a consistent approach to assessment, is resource-sparing, can be tailored to meet the specific needs of patients, can be used with audio/video for low literacy, provides a real-time summary for patients/providers,achieves similar or higher rates of disclosure of violence and mental health problems, and is preferred by patients because they perceive it as more anonymous compared to interviews or questionnaires. However, psychosocial assessment on its own is ineffective in preventing or treating mood disorders and unethical in the absence of treatment options. As such, many providers do not assess pregnant women for mood disorders because non-pharmacological treatments are frequently unavailable and pregnant women prefer them. Cognitive behavioural therapy (CBT) is a highly effective, non-pharmacological treatment for depression and anxiety and is recommended by perinatal national Australian guidelines as a potentially effective EARLY intervention for reducing the risk of maternal-child outcomes.

Interventions

BEHAVIORALCognitive Behavioral Therapy

Cognitive Behavioral Therapy- an effective, non-pharmacological treatment for depression and anxiety.

Sponsors

Norlien Foundation
CollaboratorOTHER
Women and Children's Health Research Institute, Canada
CollaboratorOTHER
University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Pregnant women will be eligible for Phase 2 if they are: 1. \< 28 weeks gestation (to provide the opportunity to complete 6 modules and follow-up questionnaires prior to delivery) 2. able to speak/read English; and (3) willing to complete email questionnaires

Exclusion criteria

1. \>28 weeks gestation 2. unable to speak/read English 3. unable to complete email questionnaires

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome of this study is the feasibility/acceptability of integrated psychosocial care and its components.6 weeks post randomizationFeasibility/acceptability of the intervention will be assessed through individual face-to-face or telephone-based semi-structured qualitative interviews of both clinic staff and women in the intervention group. The field does not allow for all questions to be provided. Sample question for clinic staff is 'What aspects made it easy/challenging to use the tablet for prenatal assessment as part of routine prenatal care?' Sample questions for intervention group participants: 1)How did you feel about answering these kinds of questions on a tablet?; 2)Please describe any concerns you had about answering these questions on a tablet; 3)How would you prefer the results to be shared with you

Secondary

MeasureTime frameDescription
Maternal copingon recruitment, 6 weeks post-randomization and 3 months postpartumThe Brief Cope Self-reported by mother on emailed questionnaire
Relationship Adjustmenton recruitment, 6 weeks post-randomization and 3 months postpartumScale: Dyadic Adjustment Scale, DAS-7 Self-reported by mother on emailed questionnaire
Parenting Stress3 months postpartumParenting Stress Scale Self-reported by mother
Maternal depression, anxiety, stresson recruitment, 6 weeks post randomization and 3 months postpartumDepression, Anxiety, and Stress Scale (DASS-21) Self-reported by mother on emailed questionnaire
Maternal-infant attachment3 months postpartumMaternal Attachment Inventory (MAI) Self-reported by mother on emailed questionnaire
Trait anxietyon recruitment, 6 weeks postrandomization, 3 months postpartumState Trait Anxiety Inventory (STAI) Self-reported by mother on emailed questionnaire
Parenting competence3 months postpartumParenting Sense of Competence Scale Self-reported by mother on emailed questionnaire

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026